NEW YORK (GenomeWeb News) – Clinical research and pharmaceutical services firm Covance said yesterday that it has closed its acquisition of Merck's Seattle-based gene expression lab.
The financial terms of the purchase, announced last month, were not disclosed, but Merck has agreed to purchase of a five-year genomic analysis services contract worth $145 million as part of the deal.